Enflurane and methoxyflurane metabolism at anesthetic and at subanesthetic concentrations.
In an attempt to determine the importance of concentration of an anesthetic agent as a determinant of the extent of its biotransformation, we measured fluoride excretion in groups of Fischer 344 rats treated with one of several subanesthetic or an anesthetic concentration (1 MAC) of either enflurane or methoxyflurane. Anesthetic administrations (2.0% enflurane or 0.26% methoxyflurane) ranged from 0.15 hours (9 minutes) to 4.8 hours. Subanesthetic exposures, all of 48 hours duration, ranged in concentration from 0.2% enflurane to 0.0016% methoxyflurane. Greatest metabolism occurred at the lowest concentration time (MAC-hours) of subanesthetic administrations and at the shortest duration of anesthetic exposure. Increasing time in the case of anesthetizing exposures, or concentration in subanesthetic exposures, increased the amount of metabolite produced. However, the increased production of metabolite was not proportional to the increase of concentration or duration of exposure. Enzyme induction was ruled out as an important factor in the larger amount of metabolism seen during the subanesthetic exposures. Therefore, the exposure of a patient to the metabolites of an anesthetic is actually low although the anesthetic is administered at a high concentration.
D000769:Anesthesia, Inhalation; D000818:Animals; D004737:Enflurane / Q000008:administration & dosage / Q000378:metabolism*; D004790:Enzyme Induction; D005459:Fluorides / Q000378:metabolism; D008297:Male; D008733:Methoxyflurane / Q000008:administration & dosage / Q000378:metabolism*; D008738:Methyl Ethers / Q000378:metabolism*; D008862:Microsomes, Liver / Q000201:enzymology; D051381:Rats; D011916:Rats, Inbred F344; D013997:Time Factors
D008738:Methyl Ethers; D008733:Methoxyflurane; D004737:Enflurane; D005459:Fluorides